YOR082C Antibody

What is YOR082C and why is it important in yeast research?

YOR082C is a yeast gene designation in Saccharomyces cerevisiae that encodes a protein associated with chromatin regulation. The protein is part of the EPC (Enhancement of Polycomb) family, which plays critical roles in chromatin modification and transcriptional regulation. EPC proteins function as components of the NuA4/TIP60 histone acetyltransferase complex, which is evolutionarily conserved from yeast to humans . Understanding YOR082C is particularly important as it provides insights into fundamental cellular processes including gene expression regulation, DNA repair, and cellular differentiation. Research on this yeast protein can inform our understanding of homologous proteins in more complex organisms, including humans, where EPC homologs have been implicated in cancer and developmental disorders .

How can I verify the specificity of a YOR082C antibody?

Validating antibody specificity is crucial before proceeding with experiments. For YOR082C antibody validation, implement the following approaches:

• Genetic knockout controls: Test the antibody against wild-type yeast and YOR082C knockout strains. A specific antibody will show signal in wild-type samples but not in knockout samples .

• Western blot analysis: Run protein extracts from both wild-type and knockout yeast strains. A specific antibody should detect a band of the predicted molecular weight only in the wild-type sample .

• Immunoprecipitation followed by mass spectrometry: This confirms whether the antibody pulls down the intended target and identifies potential cross-reactivities .

• Orthogonal validation: Compare results with alternative detection methods or different antibodies against the same target .

The YCharOS initiative demonstrates that antibodies showing poor performance in one application may not necessarily perform poorly in others, so validation should be conducted for each specific application .

What are the recommended fixation methods for immunofluorescence when using YOR082C antibody?

For optimal immunofluorescence results with YOR082C antibody in yeast cells:

• Paraformaldehyde fixation: Use 3.7% paraformaldehyde for 30 minutes at room temperature, which preserves protein epitopes while maintaining cellular structure.

• Methanol/acetone fixation: For some epitopes that may be masked during aldehyde fixation, a 10-minute fixation in cold methanol:acetone (1:1) can be effective.

• Spheroplasting: Prior to fixation, create spheroplasts by digesting the yeast cell wall with enzymatic treatments (typically zymolyase in sorbitol buffer) to improve antibody penetration.

Optimization is essential since fixation can affect epitope recognition. As noted in antibody characterization studies, staining protocols may need to be tailored specifically for yeast cells, and poor immunofluorescence performance often reflects inherent antibody limitations rather than protocol issues .

How can I optimize Western blot protocols for YOR082C antibody?

For optimal Western blot results with YOR082C antibody:

• Sample preparation:

  • Culture yeast in YPAD medium (Yeast peptone dextrose supplemented with adenine)

  • Use efficient lysis methods such as mechanical disruption with glass beads or enzymatic spheroplasting followed by detergent lysis

  • Include protease inhibitors to prevent degradation

• Gel selection and transfer:

  • Use 10-12% SDS-PAGE gels for optimal resolution

  • Transfer proteins to PVDF membranes for better protein retention

• Blocking and antibody incubation:

  • Test different blocking solutions (5% non-fat milk, 3% BSA)

  • Optimize primary antibody dilution (typically start with 1:1000 and adjust)

  • Incubate overnight at 4°C for maximum sensitivity

• Controls:

  • Include positive controls (wild-type yeast extract)

  • Include negative controls (YOR082C knockout strain extract)

  • Use loading controls (anti-tubulin or anti-actin antibodies)

• Signal detection:

  • For weak signals, consider enhanced chemiluminescence (ECL) or fluorescent secondary antibodies

  • Optimize exposure times to prevent over-saturation

Remember that Western blot performance does not necessarily predict performance in other applications like immunofluorescence or immunoprecipitation .

What is the best approach for immunoprecipitation using YOR082C antibody?

For effective immunoprecipitation with YOR082C antibody:

• Lysis conditions:

  • Use gentle lysis buffers containing 0.1-0.5% NP-40 or Triton X-100

  • Include salt concentrations (150-300 mM NaCl) that maintain protein-protein interactions

  • Add protease inhibitors, phosphatase inhibitors, and EDTA to preserve protein integrity

• Pre-clearing:

  • Pre-clear lysates with protein A/G beads to reduce non-specific binding

  • Remove cellular debris by centrifugation at 14,000 × g for 10 minutes

• Antibody binding:

  • Test different antibody amounts (typically 2-5 μg per IP)

  • Incubate with lysate overnight at 4°C with gentle rotation

• Bead selection:

  • Choose appropriate beads (Protein A, Protein G, or magnetic beads) based on antibody isotype

  • Use sufficient beads (typically 20-50 μl of bead slurry) per IP reaction

• Washing and elution:

  • Perform 3-5 stringent washes to reduce background

  • Elute proteins with either SDS sample buffer for Western blot analysis or gentler elution for functional studies

• Controls:

  • Include IgG control to identify non-specific interactions

  • Perform parallel IP with lysate from YOR082C knockout strain

This approach aligns with the comprehensive methodologies used by initiatives like YCharOS for antibody characterization .

Can YOR082C antibody be used for chromatin immunoprecipitation (ChIP)?

YOR082C antibody can be used for ChIP with the following considerations:

• Crosslinking optimization:

  • For yeast cells, use 1% formaldehyde for 15-20 minutes at room temperature

  • Quench with 125 mM glycine for 5 minutes

• Chromatin preparation:

  • Lyse cells with glass beads or spheroplasting followed by detergent lysis

  • Sonicate to achieve DNA fragments of 200-500 bp (verify fragment size by agarose gel)

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads

  • Incubate with YOR082C antibody overnight at 4°C (typically 2-5 μg)

  • Include appropriate controls (IgG, input sample, positive control antibody)

• Washing and elution:

  • Perform sequential washes with increasing stringency

  • Elute DNA-protein complexes and reverse crosslinks (65°C overnight)

• DNA purification and analysis:

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Analyze by qPCR, sequencing, or microarray

• Validation:

  • Confirm enrichment at known binding sites

  • Compare results with published ChIP-seq datasets if available

The specificity demonstrated in Western blot does not guarantee similar specificity in ChIP applications, emphasizing the need for rigorous validation for this specific application .

How can I integrate YOR082C antibody data with active learning approaches for binding prediction?

Integrating YOR082C antibody experimental data with active learning approaches:

• Initial data collection:

  • Generate a small dataset of binding interactions between YOR082C antibody and various antigens/epitopes

  • Include both positive and negative binding results with quantitative measurements

• Machine learning model implementation:

  • Develop initial prediction models based on antibody-antigen features

  • Consider structural features, amino acid composition, and physicochemical properties

• Active learning framework setup:

  • Implement an iterative framework that selects the most informative experiments to perform next

  • Focus on out-of-distribution predictions to improve model generalization

• Experimental validation cycle:

  • Based on model suggestions, perform targeted experiments with YOR082C antibody

  • Update the model with new experimental results

  • Repeat the cycle to progressively improve prediction accuracy

• Performance evaluation:

  • Use metrics such as precision, recall, and F1-score to evaluate model performance

  • Compare with random sampling strategies to quantify improvement

This approach can reduce the number of required experiments by up to 35% and accelerate the learning process significantly compared to random experimental selection, as demonstrated in related antibody-antigen binding research .

What techniques can reveal the interaction network of YOR082C protein?

To elucidate the interaction network of YOR082C protein:

• Affinity purification coupled with mass spectrometry (AP-MS):

  • Use YOR082C antibody for immunoprecipitation

  • Identify co-precipitated proteins via mass spectrometry

  • Distinguish specific interactions from contaminants using statistical methods

• Proximity-dependent biotin identification (BioID):

  • Express YOR082C fused to a biotin ligase (BirA*)

  • Identify proteins in proximity through streptavidin pull-down and mass spectrometry

  • Compare with controls to identify specific proximal proteins

• Yeast two-hybrid screening:

  • Use YOR082C as bait to screen yeast genomic libraries

  • Validate positive interactions with co-immunoprecipitation using YOR082C antibody

• Cross-linking mass spectrometry (XL-MS):

  • Cross-link protein complexes in vivo or in vitro

  • Digest and analyze by mass spectrometry

  • Identify direct protein-protein interactions and their interfaces

• Integration with existing datasets:

  • Compare identified interactions with known NuA4/TIP60 complex components

  • Cross-reference with published chromatin-associated protein networks

  • Look for evolutionary conservation of interactions seen in other organisms

Based on research with EPC family proteins, YOR082C likely participates in multiple protein complexes with diverse functions beyond its canonical role in the NuA4 complex .

How can I investigate the role of YOR082C in chromatin regulation using antibody-based approaches?

To investigate YOR082C's role in chromatin regulation:

• ChIP-seq analysis:

  • Perform ChIP using YOR082C antibody followed by next-generation sequencing

  • Map genome-wide binding sites and identify enriched motifs

  • Correlate binding with gene expression data

• Sequential ChIP (Re-ChIP):

  • Perform first ChIP with YOR082C antibody

  • Perform second ChIP with antibodies against histone modifications or transcription factors

  • Identify genomic regions where YOR082C co-localizes with specific factors

• Chromatin accessibility correlation:

  • Compare YOR082C binding sites with ATAC-seq or DNase-seq data

  • Determine if YOR082C associates with open or closed chromatin regions

• Histone modification analysis:

  • Perform ChIP-seq for various histone modifications in wild-type and YOR082C mutant strains

  • Identify modifications affected by YOR082C activity

  • Focus on acetylation marks given YOR082C's association with histone acetyltransferase complexes

• Functional genomics integration:

  • Combine ChIP-seq data with RNA-seq from YOR082C deletion or depletion experiments

  • Identify direct transcriptional targets

  • Perform Gene Ontology analysis to identify regulated biological processes

This multi-faceted approach aligns with studies of EPC family proteins that have revealed roles in diverse processes including transcriptional regulation and DNA damage response .

What are common pitfalls when working with YOR082C antibody and how can they be addressed?

Common pitfalls and solutions when working with YOR082C antibody:

• Non-specific binding:

  • Pitfall: Multiple bands in Western blot or high background in immunofluorescence

  • Solution: Increase blocking time/concentration, optimize antibody dilution, include competing proteins (BSA, non-fat milk), validate with knockout controls

• Weak or no signal:

  • Pitfall: Inability to detect YOR082C despite proper technique

  • Solution: Verify protein expression levels, test alternative epitope exposure methods (different lysis buffers, heat treatment), try different detection systems

• Epitope masking:

  • Pitfall: YOR082C may interact with other proteins that mask antibody recognition sites

  • Solution: Test different lysis conditions that may disrupt protein-protein interactions

• Batch-to-batch variation:

  • Pitfall: Inconsistent results with different lots of the same antibody

  • Solution: Validate each new batch, maintain detailed records of antibody performance

• Cross-reactivity with related proteins:

  • Pitfall: Antibody may recognize both YOR082C and related proteins

  • Solution: Confirm specificity with knockout controls, perform peptide competition assays

The YCharOS initiative has demonstrated that comprehensive antibody characterization can help identify and address these common issues early in experimental design .

How can I quantitatively assess YOR082C protein levels in different yeast strains?

For quantitative assessment of YOR082C protein levels:

• Quantitative Western blotting:

  • Use infrared fluorescent secondary antibodies or quantitative chemiluminescence

  • Include standard curves with recombinant protein if available

  • Normalize to multiple loading controls (e.g., actin, tubulin)

  • Use software such as ImageJ for densitometry analysis

• ELISA development:

  • Develop a sandwich ELISA using YOR082C antibody as capture or detection antibody

  • Create standard curves with recombinant YOR082C protein

  • Optimize blocking, washing, and detection conditions

• Mass spectrometry-based quantification:

  • Use selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

  • Include isotopically labeled peptide standards for absolute quantification

  • Monitor multiple peptides from YOR082C for reliable quantification

• Flow cytometry (for tagged versions):

  • Create GFP or other fluorescent protein fusions of YOR082C

  • Use flow cytometry to quantify expression levels at single-cell resolution

  • Correlate with antibody staining for validation

• Normalization strategies:

  • Normalize to cell number, total protein content, or housekeeping proteins

  • Consider the growth phase and culture conditions when comparing strains

These approaches allow for reliable quantitative comparisons between different yeast strains and experimental conditions.

How should I store and handle YOR082C antibody to maintain its activity?

For optimal storage and handling of YOR082C antibody:

• Long-term storage:

  • Store concentrated antibody (>1 mg/mL) at -80°C in small aliquots

  • Store working dilutions at -20°C

  • Avoid repeated freeze-thaw cycles (limit to <5 cycles)

• Short-term storage:

  • Store at 4°C for up to 2 weeks if in frequent use

  • Add preservatives like sodium azide (0.02%) for solutions stored at 4°C

  • Monitor for microbial contamination

• Handling precautions:

  • Avoid prolonged exposure to room temperature

  • Centrifuge briefly before opening tubes to collect liquid at the bottom

  • Use sterile technique when handling antibody solutions

• Dilution considerations:

  • Use high-quality, sterile buffers (typically PBS) for dilutions

  • Include carrier proteins (0.1-0.5% BSA) in dilute solutions to prevent adhesion to tubes

  • Record all dilution steps and storage conditions

• Documentation:

  • Maintain detailed records of antibody source, lot number, and performance

  • Record freeze-thaw cycles and storage duration

  • Document performance changes over time

Proper storage and handling are critical factors affecting antibody performance across all applications and can significantly impact experimental reproducibility.

How can machine learning improve the analysis of YOR082C antibody-based experiments?

Machine learning approaches can enhance YOR082C antibody experiments:

• Image analysis automation:

  • Train neural networks to identify subcellular localization patterns in immunofluorescence

  • Develop algorithms for unbiased quantification of colocalization with other proteins

  • Implement automated detection of phenotypic changes in YOR082C mutants

• Binding prediction optimization:

  • Use active learning strategies to predict optimal antibody binding conditions

  • Reduce experimental iterations needed for optimization by up to 35%

  • Focus on out-of-distribution prediction for novel experimental setups

• Integrative data analysis:

  • Combine data from multiple antibody-based techniques (ChIP-seq, IP-MS, Western blot)

  • Identify patterns and relationships not apparent in individual datasets

  • Generate testable hypotheses about YOR082C function

• Experimental design optimization:

  • Predict the most informative experiments to perform next

  • Reduce the number of required experiments through strategic selection

  • Accelerate research progress by 28 steps compared to random experimental selection

• Signal-to-noise enhancement:

  • Develop algorithms to distinguish specific from non-specific signals

  • Improve detection limits in experiments with weak YOR082C expression

  • Compensate for batch effects across multiple experiments

These machine learning approaches align with current trends in antibody research and can significantly improve experimental efficiency and data quality .

How can I investigate YOR082C's role in DNA damage response pathways?

To investigate YOR082C's role in DNA damage response:

• DNA damage induction and monitoring:

  • Treat yeast cells with DNA-damaging agents (UV, MMS, hydroxyurea)

  • Monitor YOR082C localization changes using immunofluorescence

  • Quantify recruitment kinetics to damage sites

• Chromatin association dynamics:

  • Perform ChIP-seq with YOR082C antibody before and after DNA damage

  • Identify damage-specific binding sites and enriched genomic features

  • Compare with known DNA repair factor binding sites

• Protein interaction changes:

  • Use immunoprecipitation with YOR082C antibody followed by mass spectrometry

  • Compare protein interactions in normal and damaged conditions

  • Focus on damage-specific interaction partners

• Genetic interaction analysis:

  • Create double mutants of YOR082C with known DNA repair genes

  • Assess synthetic phenotypes using survival assays after DNA damage

  • Use antibodies to monitor localization changes in genetic backgrounds

• Post-translational modification analysis:

  • Use phospho-specific antibodies to monitor YOR082C modification after damage

  • Perform mass spectrometry to identify all modifications

  • Correlate modifications with functional changes

This approach builds on the known involvement of EPC family proteins in DNA damage response pathways through their association with the NuA4/TIP60 complex, which has established roles in double-strand break repair .

What methods can detect contradictory results when using different YOR082C antibodies?

To detect and resolve contradictory results with different YOR082C antibodies:

• Comprehensive antibody validation:

  • Test all antibodies against wild-type and YOR082C knockout strains

  • Compare epitope recognition sites between antibodies

  • Document specific experimental conditions where discrepancies occur

• Cross-validation with orthogonal techniques:

  • Verify findings with tagged versions of YOR082C (GFP, FLAG, etc.)

  • Use mass spectrometry to confirm protein identity in immunoprecipitates

  • Compare with published data on YOR082C

• Systematic analysis of discrepancies:

  • Create a matrix comparing antibody performance across applications

  • Identify patterns in discrepancies (e.g., nuclear vs. cytoplasmic staining)

  • Test whether discrepancies relate to specific domains or protein states

• Controlled variable testing:

  • Systematically vary experimental conditions (fixation, buffer composition)

  • Determine if discrepancies are condition-dependent

  • Identify optimal conditions for each antibody

• Statistical analysis framework:

  • Implement Bland-Altman plots to visualize agreement between antibodies

  • Calculate concordance correlation coefficients

  • Use hierarchical clustering to group antibodies by performance similarity

The YCharOS initiative has demonstrated that comprehensive antibody characterization can reveal significant performance differences between antibodies targeting the same protein, emphasizing the importance of thorough validation .